Contact us Oncology and Hematology HOMEINNOVATIONS & THERAPEUTIC EXPERTISETHERAPEUTIC AREASONCOLOGY AND HEMATOLOGY Providing you with experience and expertise to successfully design and operationalize your trials We provide clinical, consulting, and operational expertise, combined with years of experience in clinical research, to support clinical development in all major therapeutic classes and types of cancer. These range from molecularly targeted agents to antibody-based immunotherapies, cellular and gene therapies, antibody-drug conjugates, novel cytokines, and radiopharmaceuticals. Our experience extends across all phases of research, from Phase 0 healthy volunteer trials to Phase IV post-approval safety studies. Our consulting group includes former regulators and HTA assessors who use their first-hand experience to help design, optimize and streamline trials to more efficiently address the requirements of regulators and payers. Our Parexel Oncology Center of Excellence (CoE) is at the forefront of these novel therapies. We combine an Early Advisory Service of medical, regulatory, genomics and biostatistical experts with an experienced multi-disciplinary team and key technology platform partnerships. Our therapeutic area is differentiated by: A dedicated group of therapeutically aligned individuals who are passionate about the science and helping patients, with academic, regulatory and industry backgrounds as well as direct clinical experience (some continuing to provide patient care), who are easy to work with and eager to collaborate to bring your drugs to market as fast as possible. Extensive experience and expertise across multiple indications, drug types and trial designs, including in-depth understanding of global standards of care and the competitive landscape. Innovative approaches including adaptive designs, basket, umbrella and platform studies and model-based dose escalation trials. In addition, Parexel has extensive expertise in use of precision medicine as well as use of real-world data for generation of synthetic control arms. Our Patient Innovation Center is focused on tailored patient recruitment tactics and a patient-centric approach, including hybrid decentralized trials. Investigator and site relationships, which are key to successful operationalization of oncology/hematology trials. These relationships have been fostered over several years, and many of these investigators are former colleagues functioning as KOLs in their field. We Care and With HeartTM Culture, which embodies everything we do. We care about the investigators that we work with, about our sponsor colleagues and most importantly, about the patients. These patients are depending on a carefully and efficiently executed study not only for personal clinical benefit, but to bring new and effective drugs to other patients in need. Over the last 5 years, Parexel’s oncology and hematology experience has included: Specialties Gastrointestinal Cancers Parexel has been, and still is, at the forefront of many of the recent advances in GI cancer. Colon ... Expand Lung, Head and Neck Cancer At Parexel, we know that this condition is devastating for patients and families. We know that there is hope ... Expand Genitourinary Cancers Parexel’s genitourinary cancer specialists are passionate about bringing innovation to patients and supporting the ... Expand Phase I and Rare Tumors The Phase I and Rare Tumors team comprises varied backgrounds, including pediatric oncologists, clinical pharmacologists, and Early Phase ... Expand Breast and Gynecologic Cancers Breast and gynecologic cancers (ovarian, uterine, and cervical cancer) have been a highly active area of clinical research at ... Expand Benign and Malignant Hematology With over a dozen hematology-trained specialists located worldwide, the team supports clinical trials from first in human to post-registration ... Expand The Value of Patient-Centric Approaches in Oncology Watch now Oncology Center of Excellence Brochure Building oncology trials for the those who need them most. Learn more Oncology E-book New Imperatives: Adapting oncology drug development to a post-COVID world. Learn more Accelerating Oncology Clinical Trials How to accelerate oncology clinical trials through site relationships and patient insights. Read now Precision Medicine Embarking on the next era of precision medicine. Read now One Patient’s Story After a recurrence of melanoma and participating in two clinical trials, T.J. Sharpe discusses his personal experiences and how to improve clinical trials for patients. Read Now We are always available for a conversation. Select Country Afghanistan Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Colombia Comoros Congo Costa Rica Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Isle of Man Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jersey Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kosovo Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Northern Mariana Islands Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States minor outlying islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (U.S.) Wallis and Futuna Islands Yemen Zambia Zimbabwe CORPORATE LINKS About Us News Events Careers Education Investigators My Preferences Global Locations SOLUTIONS Parexel Biotech Clinical Development Consulting Medical Affairs Real-World Evidence FSP STUDIES & VOLUNTEERS About Trials Participate in a Trial GLOBAL STUDY LOCATIONS Baltimore, US Los Angeles, US London, UK Berlin, DE 275 Grove St., Suite 101C, Newton, MA 02466 +1 617 454 9300 2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713 +1 919 544 3170 © 2000-2021. Parexel International Corporation. All Rights Reserved. Privacy Policy Terms of Service Modern Slavery Statement Act By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies